26th Jan 2022 12:30
(Alliance News) - Deltex Medical Group PLC on Wednesday said it received a USD200,000 order for its current-generation TrueVue monitors from an unnamed "key" distributor in the US.
In response, shares in the company were up 5.5% at 1.27 pence each on Wednesday midday in London.
The Chichester, England-based medical devices manufacturer added that this order will also result in "attractive" ongoing contracted monthly revenue from its single-use probes that are used with the TrueVue monitors.
Furthermore, Deltex said that the order reflects the broader growth it achieved in its international division during 2021.
It explained that, due to Covid-19, it re-focused its commercial activities on territories where it was able to obtain regular access to operating rooms in collaboration with its network of distributors.
In the year 2021, revenue in this division grew by 30% to GBP830,000 from GBP600,000 the year before.
"This growth in revenues helps to demonstrate the success that Deltex Medical can achieve when it is able to access hospitals, and in particular operating rooms," it said.
By Abby Amoakuh; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical